Web-economic-crisis-health-systems-and-health-web

Web-economic-crisis-health-systems-and-health-web Web-economic-crisis-health-systems-and-health-web

dracinthiagep
from dracinthiagep More from this publisher
18.06.2015 Views

Country profiles of health system responses to the crisis | Germany 389 Changes to health coverage Population (entitlement) • No response reported. The benefits package • New legislation (in effect since 2011) subjects all new pharmaceutical products (automatically covered upon market introduction but at a rebated price) to evaluation of their additional therapeutic benefit; new drugs that do not demonstrate additional benefit are assigned to a reference price group after six months; prices of drugs with additional benefit are negotiated based on the degree of benefit and are applied from the 13th month after market introduction. User charges • Quarterly co-payment of €10 for GP and outpatient specialist visits abolished because of the large surpluses accumulated by the SHI system (2012). Changes to health service planning, purchasing and delivery Prices of medical goods • No response reported. Salaries and motivation of health sector workers • Adjustments to the reimbursement of ambulatory physicians were frozen (2011, 2012), but an additional €1 billion was negotiated in 2011. Payment to providers • Reimbursement of psychiatric hospitals under a DRG-like system. The reimbursement rates are updated annually (by way of negotiations) (2013). Overhead costs: restructuring the Ministry of Health and purchasing agencies • No response reported. Provider infrastructure and capital investment • No response reported. Priority setting or protocols to change access to treatments, coordination of care and patterns of use • No response reported. Waiting times • No response reported. Health promotion and prevention • No response reported.

Greece Charalampos Economou and Daphne Kaitelidou Economic trends • Real GDP per capita growth was negative in 2009 and the lowest in the European region in 2010 (-5.8%) and 2011 (-6.0%). In 2009, Greece had the largest budget deficit in the European region and has since reduced government spending as a share of its economy. • Unemployment has been increasing sharply since the onset of the crisis. • Ten-year bond rates have increased throughout the crisis and were the highest in Europe in 2011. Beginning in 2010, Greece received bailout funds from the IMF and Eurozone countries. • Health spending as a share of GDP, which had been below average even before 2008, was reduced in 2011. Per capita OOP expenditure declined in 2011 by 37.0%, a notable shift in the trend (Greece: Figs 1 and 2). Policy responses Changes to public funding for the health system • MoU bailout stipulations required public spending on health to be cut by 0.5% of GDP in 2011 and to be kept below 6% of GDP in 2012; as a result, the 2011 health budget decreased by €1.9 billion; between 2009 and 2012, public spending on health fell by 25.2% (€4 billion). • The MoU stipulated a reduction in government transfers to social health insurance for civil servants, which changed from being an open-ended commitment to cover any expenditure exceeding civil servants' own contributions (2.55% of gross earnings) to a fixed contribution rate of 5.1% of gross earnings (2011). • The Public Investment Programme provided €65 million to fund policies implemented by the Ministry of Health in 2012 and €45 million for 2013. • Contributions paid by retired civil servants were increased from 2.55% to 4% (2013).

Country profiles of <strong>health</strong> system responses to the <strong>crisis</strong> | Germany<br />

389<br />

Changes to <strong>health</strong> coverage<br />

Population (entitlement)<br />

• No response reported.<br />

The benefits package<br />

• New legislation (in effect since 2011) subjects all new pharmaceutical products<br />

(automatically covered upon market introduction but at a rebated price) to<br />

evaluation of their additional therapeutic benefit; new drugs that do not<br />

demonstrate additional benefit are assigned to a reference price group after six<br />

months; prices of drugs with additional benefit are negotiated based on the degree<br />

of benefit <strong>and</strong> are applied from the 13th month after market introduction.<br />

User charges<br />

• Quarterly co-payment of €10 for GP <strong>and</strong> outpatient specialist visits abolished<br />

because of the large surpluses accumulated by the SHI system (2012).<br />

Changes to <strong>health</strong> service planning, purchasing <strong>and</strong> delivery<br />

Prices of medical goods<br />

• No response reported.<br />

Salaries <strong>and</strong> motivation of <strong>health</strong> sector workers<br />

• Adjustments to the reimbursement of ambulatory physicians were frozen<br />

(2011, 2012), but an additional €1 billion was negotiated in 2011.<br />

Payment to providers<br />

• Reimbursement of psychiatric hospitals under a DRG-like system. The<br />

reimbursement rates are updated annually (by way of negotiations) (2013).<br />

Overhead costs: restructuring the Ministry of Health <strong>and</strong> purchasing agencies<br />

• No response reported.<br />

Provider infrastructure <strong>and</strong> capital investment<br />

• No response reported.<br />

Priority setting or protocols to change access to treatments, coordination<br />

of care <strong>and</strong> patterns of use<br />

• No response reported.<br />

Waiting times<br />

• No response reported.<br />

Health promotion <strong>and</strong> prevention<br />

• No response reported.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!